Twenty-One–Gene Assay: Challenges and Promises in Translating Personal Genomics and Whole-Genome Scans Into Personalized Treatment of Breast Cancer

Personal Genomics and Genome-Wide Association Studies: Novel Discoveries but Limitations for Practical Personalized Medicine

(2008) Dimitrios H. Roukos   ANNALS OF SURGICAL ONCOLOGY

Molecular medicine, gene-expression profiling and molecular diagnostics: putting the cart before the horse

(2008) Stephen A Bustin   Biomarkers in Medicine

Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery

(2008) Dimitrios H Roukos   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Assessing both genetic variation (SNPs/CNVs) and gene–environment interactions may lead to personalized gastric cancer prevention

(2008) Dimitrios H Roukos   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

An Ideal Prognostic Test for Estrogen Receptor–Positive Breast Cancer?

(2008) Soonmyung Paik et al.   JOURNAL OF CLINICAL ONCOLOGY

Genomics and Challenges Toward Personalized Breast Cancer Local Control

(2008) Dimitrios H. Roukos et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

(2008) Lori J. Goldstein et al.   JOURNAL OF CLINICAL ONCOLOGY

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Letting the Genome out of the Bottle — Will We Get Our Wish?

(2008) David J. Hunter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer

(2008) Paul D.P. Pharoah et al.   NEW ENGLAND JOURNAL OF MEDICINE

Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies

(2007) Dimitrios H Roukos   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS